Indications

Cardiovascular Diseases

  • 30+ clinical sites in Bulgaria, Germany, Poland
  • 30+ investigators in  cardiology

Severe Heart Failure

  • phase III trials in 200 patients

Ischaemic Heart Disease

  • phase III trial